Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06463340 · ClinicalTrials.gov registry record · Phase 1

Study of SGR-3515 In Participants With Advanced Solid Tumors.

A Phase 1 study of Advanced Solid Tumor, sponsored by Schrödinger.

Recruiting
Registry status
Phase 1
Development phase
52
Enrollment target
14
Study locations

NCT06463340 is a Phase 1 study of Advanced Solid Tumor that is actively recruiting participants, run by Schrödinger. The registered enrollment target is 52 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (73% lower). The trial reports 14 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06463340, a Phase 1 study of Advanced Solid Tumor, is actively recruiting participants, sponsored by Schrödinger.

RECRUITING
Registry status
Phase 1
Development phase
52 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this study is to learn about the effects of a new study drug, called SGR-3515 that may be a treatment for advanced solid tumors.

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG SGR-3515

Study Locations (14)

Michigan

  • University of Michigan - Ann Arbor
  • Karmanos Cancer Institute - Detroit

Ohio

  • University of Cincinnati Medical Center - Cincinnati
  • Ohio State University - Columbus

Tennessee

  • Sarah Cannon Research Institute - Nashville
  • Vanderbilt-Ingram Cancer Center/Henry-Joyce Cancer Clinic - Nashville

Connecticut

  • Yale University, Yale Cancer Center - New Haven

Illinois

  • Northwestern University - Chicago

New York

  • Icahn School of Medicine at Mount Sinai - New York

North Carolina

  • Levine Cancer Institute - Charlotte

Oklahoma

  • Stephenson Cancer Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2024-06-18
Est. Completion 2026-12-31
Phase Phase 1

Sponsor

Schrödinger

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06463340

The ClinicalTrials.gov registry entry for NCT06463340 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (73% lower). The listed sponsor is Schrödinger, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which SGR-3515 is the first listed.

NCT06463340 reports 14 study locations spanning 11 distinct geographic areas - top geographies include Michigan, Ohio, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06463340 about?

NCT06463340 is a clinical study titled "Study of SGR-3515 In Participants With Advanced Solid Tumors.". The purpose of this study is to learn about the effects of a new study drug, called SGR-3515 that may be a treatment for advanced solid tumors.

What is the current status of trial NCT06463340?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2024-06-18. Estimated completion is 2026-12-31.

What conditions does trial NCT06463340 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT06463340?

The interventions under investigation include: SGR-3515 (DRUG).

Who is sponsoring clinical trial NCT06463340?

This trial is sponsored by Schrödinger, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06463340 being conducted?

This trial has 14 study locations across Connecticut, Illinois, Michigan, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.